• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺磨玻璃密度结节楔形切除术的长期预后

Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.

作者信息

Cho Jong Ho, Choi Yong Soo, Kim Jhingook, Kim Hong Kwan, Zo Jae Ill, Shim Young Mog

机构信息

Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Ann Thorac Surg. 2015 Jan;99(1):218-22. doi: 10.1016/j.athoracsur.2014.07.068. Epub 2014 Nov 15.

DOI:10.1016/j.athoracsur.2014.07.068
PMID:25440277
Abstract

BACKGROUND

We aimed to characterize ground-glass opacity (GGO) nodules and evaluate the prognosis of clinical stage IA lung adenocarcinoma with GGO nodules after wedge resection.

METHODS

Patients who underwent wedge resection for early stage lung cancer and proven adenocarcinoma on postoperative pathologic report were enrolled in the study between 2004 and 2010. Radiologic findings of the main tumor were evaluated for ground-glass opacities with chest computed tomography (CT). We divided patients into two groups based on the consolidation-to-tumor ratio (C/T ratio ≤ 0.25, pure GGO group; C/T ratio > 0.25, mixed GGO group). Overall survival and recurrence-free survival were analyzed for all patients.

RESULTS

A total of 97 patients were included in our study. Among these, 71 patients were categorized into the pure GGO group and 26 patients into the mixed GGO group. The 5-year overall survival rate was 98.6% in the pure GGO group and 95.5% in the mixed GGO group (p = 0.663). Five patients (5.1%) experienced recurrences; only 1 patient (1/71, 1.4%) in the pure GGO group and 4 patients (4/26, 15.3%) in the mixed GGO group had recurrence.

CONCLUSIONS

GGO-dominant clinical stage IA lung adenocarcinoma (pure GGO group) showed an excellent prognosis. Wedge resection should be carefully considered for patients with mixed GGO nodules (C/T ratio >0.25) because of the high recurrence rate. Radiologic noninvasiveness (C/T ratio ≤ 0.25) might be a good indicator for candidates for sublobar resection in cases of early stage lung adenocarcinoma.

摘要

背景

我们旨在对磨玻璃影(GGO)结节进行特征描述,并评估楔形切除术后伴有GGO结节的临床IA期肺腺癌的预后。

方法

纳入2004年至2010年间因早期肺癌接受楔形切除术且术后病理报告证实为腺癌的患者。通过胸部计算机断层扫描(CT)评估主要肿瘤的影像学表现,以确定磨玻璃影情况。根据实性成分与肿瘤比例(C/T比例≤0.25,纯GGO组;C/T比例>0.25,混合GGO组)将患者分为两组。分析所有患者的总生存期和无复发生存期。

结果

我们的研究共纳入97例患者。其中,71例患者被归类为纯GGO组,26例患者被归类为混合GGO组。纯GGO组的5年总生存率为98.6%,混合GGO组为95.5%(p = 0.663)。5例患者(5.1%)出现复发;纯GGO组仅1例患者(1/71,1.4%)复发,混合GGO组有4例患者(4/26,15.3%)复发。

结论

以GGO为主的临床IA期肺腺癌(纯GGO组)预后良好。对于混合GGO结节(C/T比例>0.25)的患者,由于复发率高,应谨慎考虑楔形切除术。影像学上的非实性(C/T比例≤0.25)可能是早期肺腺癌亚肺叶切除候选患者的良好指标。

相似文献

1
Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.肺磨玻璃密度结节楔形切除术的长期预后
Ann Thorac Surg. 2015 Jan;99(1):218-22. doi: 10.1016/j.athoracsur.2014.07.068. Epub 2014 Nov 15.
2
Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.磨玻璃密度为主的临床ⅠA 期肺腺癌的亚肺叶切除术式选择:楔形切除术或肺段切除术。
Chest. 2014 Jan;145(1):66-71. doi: 10.1378/chest.13-1094.
3
How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.我们应该如何处理高分辨率计算机断层扫描上的小局灶性纯磨玻璃密度结节?单机构经验。
Surg Oncol. 2015 Sep;24(3):258-63. doi: 10.1016/j.suronc.2015.08.004. Epub 2015 Aug 13.
4
Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings.肺部多灶性磨玻璃影的外科治疗:临床病理与影像学表现的相关性
Thorac Cardiovasc Surg. 2017 Mar;65(2):142-149. doi: 10.1055/s-0036-1572437. Epub 2016 Feb 22.
5
Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinoma.多灶性、鳞屑样型肺腺癌中,主瘤切除后的生存情况和进展风险因素。
J Thorac Cardiovasc Surg. 2017 Dec;154(6):2092-2099.e2. doi: 10.1016/j.jtcvs.2017.07.034. Epub 2017 Aug 1.
6
Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.临床ⅠA 期磨玻璃结节型腺癌患者复发的危险因素。
Clin Lung Cancer. 2018 Sep;19(5):e609-e617. doi: 10.1016/j.cllc.2018.04.020. Epub 2018 May 5.
7
Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.对比解剖性肺段切除术与肺叶切除术治疗临床ⅠA 期肺腺癌的肿瘤学结果:多中心研究中的倾向性评分匹配分析。
J Thorac Cardiovasc Surg. 2013 Aug;146(2):358-64. doi: 10.1016/j.jtcvs.2013.02.008. Epub 2013 Mar 8.
8
Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.临床ⅠA 期影像学纯磨玻璃密度肺腺癌行亚肺叶切除术的适应证。
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1100-1108. doi: 10.1016/j.jtcvs.2017.03.153. Epub 2017 May 18.
9
Comparisons of clinical outcomes in patients with and without a preoperative tissue diagnosis in the persistent malignant-looking, ground-glass-opacity nodules.持续性恶性磨玻璃样结节患者术前有无组织诊断的临床结局比较。
Medicine (Baltimore). 2016 Aug;95(34):e4359. doi: 10.1097/MD.0000000000004359.
10
Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.磨玻璃密度影是 I 期肺腺癌病理分期的强有力预测指标。
Ann Thorac Surg. 2019 Jul;108(1):249-255. doi: 10.1016/j.athoracsur.2019.01.079. Epub 2019 Mar 12.

引用本文的文献

1
Prognosis of surgically resected clinical stage 1A non-small cell lung cancers manifesting as a subsolid nodule on computed tomography including pure ground glass nodules.表现为亚实性结节(包括纯磨玻璃结节)的手术切除的临床1A期非小细胞肺癌的预后
Cochrane Database Syst Rev. 2025 Mar 19;3(3):CD016091. doi: 10.1002/14651858.CD016091.
2
Impact of histopathological subtypes on invasive lung adenocarcinoma: from epidemiology to tumour microenvironment to therapeutic strategies.组织病理学亚型对浸润性肺腺癌的影响:从流行病学到肿瘤微环境再到治疗策略
World J Surg Oncol. 2025 Feb 27;23(1):66. doi: 10.1186/s12957-025-03701-9.
3
Lobectomy bisegmentectomy for lung cancer in the left upper lobe: a retrospective comparative cohort study.
左上叶肺癌的肺叶切除术与双肺段切除术:一项回顾性比较队列研究。
J Thorac Dis. 2025 Jan 24;17(1):400-412. doi: 10.21037/jtd-2024-2199. Epub 2025 Jan 22.
4
Lung cancer screening in people who have never smoked: lessons from East Asia.从不吸烟人群的肺癌筛查:来自东亚的经验教训。
BMJ. 2025 Feb 6;388:e081674. doi: 10.1136/bmj-2024-081674.
5
Pure ground-glass opacities (GGO) lung adenocarcinoma: surgical resection is curative.纯磨玻璃影(GGO)型肺腺癌:手术切除可治愈。
J Thorac Dis. 2024 May 31;16(5):3518-3521. doi: 10.21037/jtd-23-1983. Epub 2024 May 22.
6
A clinical nomogram for predicting occult lymph node metastasis in patients with non-small-cell lung cancer ≤2 cm.用于预测直径≤2 cm的非小细胞肺癌患者隐匿性淋巴结转移的临床列线图。
Interdiscip Cardiovasc Thorac Surg. 2024 Jul 3;39(1). doi: 10.1093/icvts/ivae098.
7
Clinical and non-contrast computed tomography characteristics and disease development in patients with benign pulmonary subsolid nodules with a solid component ≤ 5 mm.实性成分≤5mm的良性肺亚实性结节患者的临床及非增强计算机断层扫描特征与疾病进展
Insights Imaging. 2024 Jan 8;15(1):6. doi: 10.1186/s13244-023-01585-5.
8
Prognostic value of consolidation-to-tumor ratio on computed tomography in NSCLC: a meta-analysis.非小细胞肺癌 CT 增强-肿瘤比值的预后价值:荟萃分析。
World J Surg Oncol. 2023 Jun 22;21(1):190. doi: 10.1186/s12957-023-03081-y.
9
[Wedge Resection of Pulmonary Nodules (≤2 cm): 
A Consensus Statement by Specialists of Thoracic Surgery (2023 Edition)].[肺结节(≤2厘米)楔形切除术:胸外科专家共识声明(2023年版)]
Zhongguo Fei Ai Za Zhi. 2023 May 20;26(5):338-347. doi: 10.3779/j.issn.1009-3419.2023.102.17.
10
A narrative review of the clinical approach to subsolid pulmonary nodules.亚实性肺结节临床处理方法的叙述性综述
Ann Transl Med. 2023 Mar 15;11(5):217. doi: 10.21037/atm-22-5246. Epub 2023 Mar 10.